CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research-Reference-Cited by-同舟云学术

CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research

Published:2018-04-25 Issue:5-6 Volume:25 Page:93-105
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Wang Dong,Wang Xian-Wang,Peng Xiao-Chun,Xiang Ying,Song Shi-Bao,Wang Ying-Ying,Chen Lin,Xin Victoria W.,Lyu Yan-Ning,Ji Jiafu,Ma Zhao-Wu,Li Cheng-Bin,Xin Hong-Wu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/s41417-018-0016-3.pdf

Reference82 articles.

1. Naldini L. Gene therapy returns to centre stage. Nature. 2015;526:351–60.

2. Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol. 2014;32:347–55.

3. Zhang F, Wen Y, Guo X. CRISPR/Cas9 for genome editing: progress, implications and challenges. Hum Mol Genet. 2014;23:R40–6. R1

4. Peng Z. Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther. 2005;16:1016–27.

5. Kohlhapp FJ, Zloza A, Kaufman HL. Talimogene laherparepvec (T-VEC) as cancer immunotherapy. Drugs Today. 2015;51:549–58.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of Oncolytic Virus;Journal of Biomedical Nanotechnology;2024-10-01

2. Current knowledge on the epidemiology and prevention of Avian leukosis virus in China;Poultry Science;2024-09

3. The binding of diruthenium (II,III) and dirhodium (II,II) paddlewheel complexes at DNA/RNA nucleobases: Computational evidences of an appreciable selectivity toward the AU base pairs;Journal of Molecular Graphics and Modelling;2024-09

4. A review of HSV pathogenesis, vaccine development, and advanced applications;Molecular Biomedicine;2024-08-29

5. Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy;Current Gene Therapy;2024-08